Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability

neurodegeneration archived 2026-04-02 0 hypotheses 0 KG edges

📓 Notebooks (8)

Top 5 Analysis: Sda 2026 04 02 Gap Aging Mouse Brain 20260402
Computational notebook for SDA-2026-04-02-gap-aging-mouse-brain-20260402
View →
SciDEX Analysis: 2026 04 02 Gap Aging Mouse Brain 20260402
Computational notebook for SDA-2026-04-02-gap-aging-mouse-brain-20260402
View →
Aging mouse brain — Analysis Notebook
Comprehensive analysis notebook
View →
Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability - Top 5 Rich Notebook
Rich notebook with gene expression, pathway enrichment, KG network, score heatmaps, and statistical analysis.
View →
Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability — Analysis Notebook
Jupyter notebook for analysis SDA-2026-04-02-gap-aging-mouse-brain-20260402: What gene expression changes in the aging m...
View →
Gene Expression in Aging Mouse Brain Predicting Neurodegeneration (v1)
What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Using Allen Brain Atlas a...
View →
Gene expression changes in aging mouse brain predicting neurodegenerative vulnerability — Rich Analysis Notebook
Enhanced notebook with gene expression, pathway enrichment, and statistical analysis for: What gene expression changes i...
View →
Aging Mouse Brain — Complement Cascade Notebook
Gene expression analysis of complement cascade in aging mouse brain.
View →

Related Wiki Pages

ANG ProteinproteinANG — AngiogeningeneC4B GenegeneNeurodegenerationdiseaseaging-neurodegenerationmechanismMechanismsindexHypothesesindexFER GenegeneDatasetsindexSection 146: Advanced Synaptic Plasticity andtherapeuticiPSC-Derived Neurons for Drug Screening in CBtherapeuticC1QB Protein — Complement Component 1 QproteinProteinsindexSynaptic Vesicle Cycle in NeurodegenerationmechanismSynaptic Plasticity Deficits in Neurodegeneramechanism

Research Question

"What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produce hypotheses about aging-neurodegeneration mechanisms."

🧠 Theorist⚠️ Skeptic💊 Domain Expert
2,114
Tokens
8
Rounds
$0.03
Est. Cost
0
Hypotheses
How this analysis was conducted: Four AI personas with distinct expertise debated this research question over 8 rounds. The Theorist proposed novel mechanisms, the Skeptic identified weaknesses, the Domain Expert assessed feasibility, and the Synthesizer integrated perspectives to score 0 hypotheses across 10 dimensions. Scroll down to see the full debate transcript and ranked results.

Scientific Debate (3 rounds) View full transcript →

Multi-agent debate between AI personas, each bringing a distinct perspective to evaluate the research question.

🧠

Theorist

Generates novel, bold hypotheses by connecting ideas across disciplines

12 tokens

[MAX TOOL ROUNDS REACHED]

⚠️

Skeptic

Challenges assumptions, identifies weaknesses, and provides counter-evidence

398 tokens

I'd be happy to critically evaluate hypotheses, but I don't see any specific hypotheses provided in your message. You mentioned "these hypotheses from the Theorist" but the actual hypotheses aren't included.

Could you please provide the specific hypotheses you'd like me to critically evaluate? Once you share them, I'll:

  • Identify specific weaknesses in the evidence and reasoning
  • **Searc
  • ...
    Read full response (799 chars)

    I'd be happy to critically evaluate hypotheses, but I don't see any specific hypotheses provided in your message. You mentioned "these hypotheses from the Theorist" but the actual hypotheses aren't included.

    Could you please provide the specific hypotheses you'd like me to critically evaluate? Once you share them, I'll:

  • Identify specific weaknesses in the evidence and reasoning
  • Search for counter-evidence using PubMed and cite specific studies with PMIDs
  • Propose alternative explanations and confounding factors
  • Design falsification experiments to test the hypotheses
  • Provide revised confidence scores based on the critical analysis
  • Please paste the hypotheses you'd like me to analyze, and I'll conduct a thorough scientific critique with proper citations.

    💊

    Domain Expert

    Assesses druggability, clinical feasibility, and commercial viability

    764 tokens

    I notice that you've referenced hypotheses to assess, but the actual hypotheses aren't included in your message. You mentioned "[MAX TOOL ROUNDS REACHED]" which suggests there may have been a previous conversation where hypotheses were generated, but I don't have access to that content.

    To provide you with a comprehensive practical feasibility assessment, I need you to share the specific hypothes

    ...
    Read full response (1,531 chars)

    I notice that you've referenced hypotheses to assess, but the actual hypotheses aren't included in your message. You mentioned "[MAX TOOL ROUNDS REACHED]" which suggests there may have been a previous conversation where hypotheses were generated, but I don't have access to that content.

    To provide you with a comprehensive practical feasibility assessment, I need you to share the specific hypotheses you'd like me to evaluate. Once you provide them, I'll conduct a thorough analysis for each hypothesis covering:

    Druggability Assessment

    • Target class and structural features
    • Binding sites and allosteric opportunities
    • Chemical tractability

    Existing Chemical Matter

    • Tool compounds and their properties
    • Clinical candidates and their status
    • FDA-approved drugs targeting similar mechanisms

    Competitive Landscape

    • Active pharmaceutical companies
    • Pipeline programs and trial status
    • Patent landscape and IP considerations

    Development Timeline & Costs

    • Preclinical development estimates (2-4 years, $10-50M)
    • Clinical development phases and costs
    • Regulatory pathway considerations

    Safety Concerns

    • Known target-related toxicities
    • Off-target effects and selectivity challenges
    • Patient population considerations

    Could you please share the specific hypotheses you'd like me to assess? I'll then use the available research tools to provide detailed, evidence-based feasibility evaluations with specific drug names, clinical trial IDs, and company information where relevant.

    Ranked Hypotheses (0)

    Following multi-persona debate and rigorous evaluation across 10 dimensions, these hypotheses emerged as the most promising therapeutic approaches.

    ⚠️ No Hypotheses Generated

    This analysis did not produce scored hypotheses. It may be incomplete or in-progress.

    Knowledge Graph Insights (0 edges)

    No knowledge graph edges recorded

    Related Wiki Pages

    ANG ProteinproteinANG — AngiogeningeneC4B GenegeneNeurodegenerationdiseaseaging-neurodegenerationmechanismMechanismsindexHypothesesindexFER GenegeneDatasetsindexSection 146: Advanced Synaptic Plasticity andtherapeuticiPSC-Derived Neurons for Drug Screening in CBtherapeuticC1QB Protein — Complement Component 1 QproteinProteinsindexSynaptic Vesicle Cycle in NeurodegenerationmechanismSynaptic Plasticity Deficits in Neurodegeneramechanism

    Figures & Visualizations (66)

    Auto-generated visualizations from the multi-agent analysis — pathway diagrams, score comparisons, evidence heatmaps, and debate impact charts.

    🧬 Pathway Diagrams (45)

    pathway C4B

    pathway C4B

    pathway C4B

    pathway C4B

    pathway C4B

    pathway C4B

    pathway C4B

    pathway C4B

    pathway C4B

    pathway C4B

    pathway C4B

    pathway C4B

    + 39 more

    💬 Debate Impact (21)

    debate impact

    debate impact

    debate overview

    debate overview

    debate overview

    debate overview

    debate overview

    debate overview

    + 17 more

    Analysis ID: SDA-2026-04-02-gap-aging-mouse-brain-20260402

    Generated by SciDEX autonomous research agent